Implementation of In-Hospital Postpartum Glucose Tolerance Testing for People with Gestational Diabetes

Abstract

Objective We aimed to evaluate uptake of the glucose tolerance test performed during delivery hospitalization as part of routine clinical care.

Study Design This is a retrospective cohort study of people with GDM at a tertiary center. We collected 9 months of postimplementation data after the in-hospital (“early”) glucose tolerance test was adopted as a routine screening option. Adherence was compared between those who elected early glucose tolerance testing versus those who deferred testing to the standard postpartum period. Bivariable statistics including demographics, care team, and postpartum testing/visit attendance were compared between those who received early testing and those who did not using chi-square, Fisher's exact, and t-tests.

Results A total of 681 patients with GDM delivered during the study period. Of those who had an early glucose tolerance test ordered (n = 408), 340 (83.3%) completed the test. Among those who did not complete an early glucose tolerance test (ordered and not completed or never ordered), only 104/341 (30.5%) completed any postpartum glucose testing in the first 12 months of postpartum. There were significant differences in characteristics in terms of race/ethnicity, insurance, type of gestational diabetes (A1GDM vs. A2GDM), diabetes medications, obstetric care provider, and delivery mode. Among those who completed early testing, 43.7% of participants had impaired glucose metabolism and 6.5% had values concerning for overt diabetes mellitus. Among those who deferred testing to the standard 6- to 12-week period, 24.0% had impaired glucose metabolism and none had overt diabetes. Those who completed an early glucose tolerance test had a lower rate of postpartum visit attendance compared with those who deferred (75.6 vs. 91.5%, p < 0.01).

Conclusion In this cohort, when the early glucose tolerance test is offered in clinical practice, adherence rates are higher than when the test is deferred until the postpartum visit.

Key Points

• Adherence rates with the early glucose tolerance test (GTT) are higher than if the testing is deferred.

• Those who completed an early GTT had a lower rate of postpartum visit attendance compared with those who deferred.

• Offering an in-hospital postpartum GTT can help address low rates of glucose testing postpartum.

Keywords

gestational diabetes - postpartum - dysglycemia - glucose tolerance testing - implementation

Note

This study was presented at American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, Baltimore Maryland, May 19 to 21, 2023.

Publikationsverlauf

Eingereicht: 09. August 2023

Angenommen: 28. Januar 2024

Accepted Manuscript online:
30. Januar 2024

Artikel online veröffentlicht:
19. Februar 2024

• References

• 1 Gestational Diabetes - Symptoms. Treatments | ADA. Accessed May 23, 2023 at: https://diabetes.org/diabetes/gestational-diabetes
• 2 ACOG Practice Bulletin No. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
• 3 Yogev Y, Xenakis EMJ, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol 2004; 191 (05) 1655-1660
• 4 Ehrenberg HM, Durnwald CP, Catalano P, Mercer BM. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol 2004; 191 (03) 969-974
• 5 Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25 (10) 1862-1868
• 6 Attanasio LB, Ranchoff BL, Cooper MI, Geissler KH. Postpartum visit attendance in the United States: a systematic review. Womens Health Issues 2022; 32 (04) 369-375
• 7 DiBari JN, Yu SM, Chao SM, Lu MC. Use of postpartum care: predictors and barriers. J Pregnancy 2014; 2014: 530769
• 8 Ruderman RS, Dahl EC, Williams BR. et al. Provider perspectives on barriers and facilitators to postpartum care for low-income individuals. Womens Health Rep (New Rochelle) 2021; 2 (01) 254-262
• 9 Werner EF, Has P, Rouse D, Clark MA. Society for Maternal-Fetal Medicine (SMFM). Two-day postpartum compared with 4- to 12-week postpartum glucose tolerance testing for women with gestational diabetes. Am J Obstet Gynecol 2020; 223 (03) 439.e1-439.e7
• 10 Periyathambi N, Parkhi D, Ghebremichael-Weldeselassie Y. et al. Machine learning prediction of non-attendance to postpartum glucose screening and subsequent risk of type 2 diabetes following gestational diabetes. PLoS One 2022; 17 (03) e0264648
• 11 Lawrence JM, Black MH, Hsu JW, Chen W, Sacks DA. Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus. Diabetes Care 2010; 33 (03) 569-576
• 12 Abu Bakar FA, Ismail TAT. Factors associated with postpartum glucose testing following gestational diabetes mellitus. Oman Med J 2021; 36 (04) e282
• 13 Russell MA, Phipps MG, Olson CL, Welch HG, Carpenter MW. Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 2006; 108 (06) 1456-1462